These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36566845)

  • 1. Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease.
    Pu Y; Fan X; Zhang Z; Guo Z; Pan Q; Gao W; Luo K; He B
    J Control Release; 2023 Feb; 354():1-18. PubMed ID: 36566845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Engineered Butyrate-Derived Polymer Nanoplatform as a Mucosa-Healing Enhancer Potentiates the Therapeutic Effect of Magnolol in Inflammatory Bowel Disease.
    Fan X; Zhang Z; Gao W; Pan Q; Luo K; He B; Pu Y
    ACS Nano; 2024 Jan; 18(1):229-244. PubMed ID: 38112525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review.
    Liu Y; Huang J; Li S; Li Z; Chen C; Qu G; Chen K; Teng Y; Ma R; Wu X; Ren J
    Biomater Sci; 2024 Feb; 12(4):837-862. PubMed ID: 38196386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
    Yang C; Merlin D
    Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances.
    Hu S; Zhao R; Xu Y; Gu Z; Zhu B; Hu J
    J Mater Chem B; 2023 Dec; 12(1):13-38. PubMed ID: 38018424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine.
    Li W; Li Y; Liu Z; Kerdsakundee N; Zhang M; Zhang F; Liu X; Bauleth-Ramos T; Lian W; Mäkilä E; Kemell M; Ding Y; Sarmento B; Wiwattanapatapee R; Salonen J; Zhang H; Hirvonen JT; Liu D; Deng X; Santos HA
    Biomaterials; 2018 Dec; 185():322-332. PubMed ID: 30267958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesopore to Macropore Transformation of Metal-Organic Framework for Drug Delivery in Inflammatory Bowel Disease.
    Yin Y; Yang J; Pan Y; Gao Y; Huang L; Luan X; Lin Z; Zhu W; Li Y; Song Y
    Adv Healthc Mater; 2021 Feb; 10(3):e2000973. PubMed ID: 33369176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease.
    Zhang S; Ermann J; Succi MD; Zhou A; Hamilton MJ; Cao B; Korzenik JR; Glickman JN; Vemula PK; Glimcher LH; Traverso G; Langer R; Karp JM
    Sci Transl Med; 2015 Aug; 7(300):300ra128. PubMed ID: 26268315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Uptake Into Inflamed Human Intestinal Tissue and Immune Cell Targeting by Wormlike Polymer Micelles.
    Gardey E; Cseresnyes Z; Sobotta FH; Eberhardt J; Haziri D; Grunert PC; Kuchenbrod MT; Gruschwitz FV; Hoeppener S; Schumann M; Gaßler N; Figge MT; Stallmach A; Brendel JC
    Small; 2024 May; 20(21):e2306482. PubMed ID: 38109123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
    Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alginate-based drug carrier systems to target inflammatory bowel disease: A review.
    Swastha D; Varsha N; Aravind S; Samyuktha KB; Yokesh MM; Balde A; Ayilya BL; Benjakul S; Kim SK; Nazeer RA
    Int J Biol Macromol; 2023 Jul; 244():125472. PubMed ID: 37336375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa.
    Dar MJ; Ali H; Khan A; Khan GM
    J Drug Target; 2017 Aug; 25(7):582-596. PubMed ID: 28277824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current pharmaceutical strategies for efficient site specific delivery in inflamed distal intestinal mucosa.
    Sharma S; Sinha VR
    J Control Release; 2018 Feb; 272():97-106. PubMed ID: 29317245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD.
    Hartwig O; Shetab Boushehri MA; Shalaby KS; Loretz B; Lamprecht A; Lehr CM
    Adv Drug Deliv Rev; 2021 Aug; 175():113828. PubMed ID: 34157320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model.
    Melero A; Draheim C; Hansen S; Giner E; Carreras JJ; Talens-Visconti R; Garrigues TM; Peris JE; Recio MC; Giner R; Lehr CM
    Eur J Pharm Biopharm; 2017 Oct; 119():361-371. PubMed ID: 28709903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric nanoparticles for the selective therapy of inflammatory bowel disease.
    Wachsmann P; Lamprecht A
    Methods Enzymol; 2012; 508():377-97. PubMed ID: 22449936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy.
    Teruel AH; Gonzalez-Alvarez I; Bermejo M; Merino V; Marcos MD; Sancenon F; Gonzalez-Alvarez M; Martinez-Mañez R
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel disease.
    Zhang C; Zeng F; Fan Z; He Z; Tai L; Peng Q; Zhang Y; Chao Z; Jiang W; Jia L; Han L
    Acta Biomater; 2023 Oct; 169():422-433. PubMed ID: 37597682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Nanomedicine: Redefining Therapeutic Paradigms for Inflammatory Bowel Disease.
    Zhang Y; Wang T; Sun M; Song Y; Huang X; Zhang S; Yang J; Zhang J
    Adv Healthc Mater; 2023 Jul; 12(19):e2300069. PubMed ID: 36929291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.